Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Trump’s wall could hit Mexican medical tourism market

What does President Trump's Mexican wall plan mean for medical travel across the border? Some Mexican hospital groups have already reported a fall in US patients, but opinion is split on what the long-term effect will be. We talk to operators in the region to find out more.

Three groups left in race to buy Oberberg

German psychiatric care provider Oberberg Gruppe is close to being sold. Healthcare Europa speaks to a source who says one big private equity group has pulled out of the already, leaving three interested parties.

Lenmed looks north 

South Africa's fourth largest hospital chain is already in Mozambique and Botswana and is keen to expand into other Sub-Saharan countries such as Nigeria, Ghana and Uganda. That might be with specialist outpatient chains.  But there are plenty of opportunities in South Africa as The Competition Commission stops the Big Three from making more inpatient acquisitions. We talk to Lenmed COO, Amil Devchand. 

Orpea drives into German ambulatory rehab

Care giant Orpea has acquired 75% of imoges, which trades as Salvea and runs a daycare rehab network in Germany through Celenus, its German rehab subsidiary. The move marks a further drive by Orpea into rehab in Germany.

UK care home giant set to pass to creditor

Ownership of the UK’s second largest care home group, Four Seasons, looks set to pass from private equity owners Terra Firma to its key creditor, US hedge fund H/2 Capital, in a move that would see the former capping its losses at £450m (€510m).

American health group buys minority stake in German hospital – but why?

Sanford Health, a US $4bn+ revenue, not-for-profit healthcare group has just bought a minority stake in privately-held Isar Klinikum, a 240-bed hospital in Munich. We talk to Sanford Health and our contacts in Germany about the deal, two of whom think there is more to it than meets the eye.

Interview: Enrique Samper, CEO, NIMGenetics

Spanish laboratory company NIMGenetics has set its sights on Latam, and says it expects to see massive growth from its newly set-up businesses in the region. Healthcare Europa speaks to founder and CEO Enrique Samper about how he’s looking abroad, while facing problems at home.

Interview: Enrique Samper, CEO, NIMGenetics

Spanish laboratory company NIMGenetics has set its sights on Latam, and says it expects to see massive growth from its newly set-up businesses in the region. Healthcare Europa speaks to founder and CEO Enrique Samper about how he's looking abroad, while facing problems at home.

Intercare deal could be a game-changer

This summer, Mediclinic, the listed South African, Europe and Mid-East hospital giant, quietly bought into Intercare, a South African outpatient, day hospital and sub-acute and rehabilitation hospital network which specialises in value-based healthcare, providing the best outcomes at the lowest costs. Here is why we think the acquisition is a game changer and why this is a business model that could be exported internationally.

Find Us